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Specific-pathogen-free guinea pigs were vaccinated with viable Mycobacterium
bovis BCG and maintained on purified, isocaloric diets containing either 30% or
7.5% casein, or commercial chow. At intervals of 4, 5, 6, and 8 weeks
postvaccination, groups of guinea pigs from each diet treatment were skin tested
with purified protein derivative and killed. Protein-deficient animals exhibited
progressive reductions in total serum proteins and albumin. Significantly greater
numbers of viable M. bovis BCG were recovered from the vaccination site and
inguinal lymph nodes of protein-deficient guinea pigs at all intervals. In contrast,
the development of delayed hypersensitivity was markedly retarded in the 7.5%
casein group and was also reduced somewhat in the 30% casein group as
compared to chow control. Peripheral blood lymphocytes from protein-deficient
animals did not respond normally in vitro to a polyclonal T cell mitogen,
phytohemagglutinin. These results demonstrate that protein-calorie malnutrition
in this model impairs the development of cell-mediated immunity as evidenced by
skin test anergy, lymphocyte hyporesponsiveness, and failure to control levels of
viable M. bovis BCG after vaccination.
Immune dysfunction secondary to malnutri-
tion is probably the most common form of
"6acquired" immunological deficiency in man.
Numerous studies have demonstrated that both
severe and moderate nutritional deficiencies are
accompanied by significant immune impairment,
particularly cell-mediated immunity in vivo and
in vitro (5, 10, 23, 34). Experimental animal
models have contributed to our appreciation of
the role of single nutrient deficiencies (2, 6)
while illustrating the differential effect of moder-
ate protein-calorie malnutrition on humoral and
cellular immune mechanisms (9, 18). Few would
dispute the association between malnutrition
and measurable perturbations of immune re-
sponse; however, the biological significance of
nutrition-mediated immune dysfunction, in man
or animals, has not been established. There
appears to be a relationship between protein
malnutrition and increased susceptibility to in-
fectious disease in humans and animals (21, 30),
but few experimental studies have included re-
sponse to infection along with other measures of
immunological status.
Mycobacterium bovis BCG vaccine is used
world-wide to prevent tuberculosis and in immu-
notherapy of some forms of cancer. Since nutri-
t Present address: Division of Nutrition, Food and Drug
Administration, Washington, D. C. 20204.
tional deficiencies occur in the majority of pre-
school children in many developing countries (8,
23), and are common in patients with malignan-
cy (28), it is critical to evaluate the impact of
malnutrition on the response to M. bovis BCG.
Several studies done in experimental animals
and human subjects suggest that protein-calorie
malnutrition impairs immunity to M. bovis BCG
(3, 34), whereas other results appear to show no
effect (25, 29). Previously, we have demonstrat-
ed that malnourished, M. bovis BCG-vaccinated
guinea pigs exhibit impaired delayed hypersensi-
tivity to purified protein derivative (PPD) and
lymphocyte hyporesponsiveness to mitogenic
stimulation in vitro (22, 24a). In contrast, we
have observed enhanced macrophage activity
under similar conditions (24b), suggesting that
acquired cellular resistance may not be affected.
In the present study, we examined the influ-
ence of a protein-deficient diet on the time-
course of M. bovis BCG infection, the develop-
ment of delayed hypersensitivity, and the
blastogenic activity of peripheral blood lympho-
cytes in M. bovis BCG-vaccinated guinea pigs.
(This work was presented in part at the Feder-
ation of American Societies for Experimental
Biology, Anaheim, Calif., April 1980 [Fed. Proc.
39:1126, 1980]; and Western Hemisphere Nutri-
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MATERIALS AND METHODS
Experimental animals. Outbred, albino, specific-
pathogen-free female guinea pigs, weighing 250 to 300
g, were obtained from a commercial source (Hartley-
COBS, Charles River Breeding Laboratories, Inc.,
Wilmington, Mass.). They were housed individually in
polycarbonate cages on stainless-steel wire mesh
floors and provided with tap water and food ad libi-
tum. Each animal was randomly assigned to an experi-
mental treatment. Body weights were recorded weekly
during the experiment.
Experimental diets. The experimental diets were
based upon the current recommended nutritional re-
quirements for guinea pigs (26). Two purified diets
containing 30 or 7.5% casein were used. These diets
were isocaloric, with the proportion of casein and
cornstarch varying inversely to provide the desired
protein content. The formulations of the basic diet,
mineral mix, and vitamin mix were published previ-
ously (24a). The casein was supplemented with argi-
nine and methionine in the dietary group receiving
30% casein. The diets were given as a powder or
mixed with tap water to form a paste. Fresh diet was
provided every other day. An additional group was
maintained on a commercial stock diet (Guinea Pig
Chow, Ralston Purina, St. Louis, Mo.) containing 18%
protein.
M. bovis BCG vaccination. On the same day the
experimental diets were started, guinea pigs were
vaccinated with viable M. bovis BCG vaccine (Copen-
hagen 1331, Statens Seruminstitut, Copenhagen, Den-
mark). Each animal received 0.1 ml of saline contain-
ing about 103 viable bacilli subcutaneously in the left
inguinal area. The viability of the vaccine was deter-
mined by plating appropriate dilutions on oleic acid
albumin agar (Difco Laboratories, Detroit, Mich.).
PPD skin tests. Delayed hypersensitivity was elicited
in M. bovis BCG-vaccinated guinea pigs two days
before sacrifice by the intradermal injection of 0.1 ml
of PPD (PPD-RT-23; Statens Seruminstitut). One dose
of PPD, 100 tuberculin units, was injected on a shaved
area of the side. The reactions were measured with a
transparent plastic ruler 48 h later, and the mean
diameter of induration was recorded in millimeters.
Autopsy procedure. Four, five, six, and eight weeks
after vaccination and initiation of the experimental
diets, groups of 5 to 7 guinea pigs from each group
were killed by cervical dislocation. The animals were
exsanguinated by cardiac puncture with a heparinized
10-ml syringe. The abdominal cavity was opened
aseptically, and the subcutaneous vaccination site and
inguinal lymph nodes draining the site were removed
to sterile petri dishes and weighed. These organs were
then homogenized in separate Teflon-glass homoge-
nizers in 2 ml of sterile 2% albumin solution, and
appropriate dilutions were plated on oleic acid albumin
agar to recover viable M. bovis BCG. The plates were
incubated for 3 to 4 weeks at 37°C, and the number of
M. bovis BCG colonies were counted. Viable counts
are expressed as mean loglo viable M. bovis BCG per
milligram (wet weight) of tissue.
Total protein content of the serum was measured
using the Lowry method (20). Protein electrophoresis
was carried out on cellulose acetate strips, which were
stained and quantified in a scanning densitometer
(DCD-16, Gelman Sciences, Inc., Ann Arbor, Mich.).
The concentration of serum albumin was calculated
using these data.
Lymphocyte blastogenesis. The response of peripher-
al blood lymphocytes to the polyclonal T cell mitogen
phytohemagglutinin (Difco) was measured by in vitro
culture (11). Whole, heparinized blood was diluted 1:6
with tissue culture medium (RPMI 1640, Microbiologi-
cal Associates, Bethesda, Md.) containing 10% fetal
bovine serum. Aliquots of 250 RI were placed in the
wells of a microtiter plate (Falcon Plastics, Oxnard,
Calif.). Triplicate cultures were stimulated with four
dilutions of phytohemagglutinin (1:10, 1:50, 1:100,
1:200) in 10 ,ul of tissue culture medium and incubated
at 37°C in a 5% CO2 atmosphere for 72 h. Each well
was then pulsed with 10 ,ul of tissue culture medium
containing 0.8 ,uCi of tritiated thymidine (6.7 mCi/
mmol; New England Nuclear Corp., Boston, Mass.).
Twenty-four hours later, the cultures were harvested
onto fiber-glass filter disks with a multiple automated
sample harvestor (Otto Hiller, Inc., Madison, Wisc.).
The disks were bleached with 5% hydrogen peroxide,
placed in liquid scintillation vials with cocktail (Omni-
fluor, New England Nuclear), and counted in a liquid
scintillation counter (Beckman LS 8000, Beckman
Instruments, Inc., Fullerton, Calif.). Counts were cor-
rected for background and quenching and adjusted to
represent the response of 106 lymphocytes. The phyto-
hemagglutinin dilution giving the optimal response was
selected for each animal and used to calculate the
blastogenic index, which was defined as the ratio of
counts per minute in mitogen-stimulated versus non-
stimulated cultures of the same animal's cells.
Statistical analysis. The analysis of variance was
used to test for the effect of dietary treatment on the
dependent variables measured. Where appropriate,
Student's t test was employed to assess the signifi-
cance of differences between group means. The confi-
dence level was set at P < 0.05.
RESULTS
Effect of diet on growth and protein status.
There was no difference between the initial
mean body weights of the 7.5% casein group
(283 ± 18 g), the 30% casein group (267 ± 20 g),
and the chow group (275 ± 18 g). The effect of
diet on the body weights of guinea pigs killed at
the four intervals is illustrated in Fig. 1. The
chow control animals were significantly heavier
than those consuming the purified diets at all
intervals. Food intake was estimated periodical-
ly, and both groups consuming purified diets
were taking in about one-fifth less food per day
than the chow controls. There was no difference
in food consumption between the 7.5 and 30%
casein groups. Between 5 and 8 weeks, the 30%
casein group gained somewhat, whereas the
7.5% casein group lost weight gradually. The
protein-deficient animals were significantly
lighter than those on the 30% casein diet at 6 and
8 weeks postvaccination.
Between 4 and 8 weeks after initiation of
experimental diets and M. bovis BCG vaccina-
tion, protein deficiency was observed to exert a
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FIG. 1. Growth of M. bovis BCG-vaccinated guin-
ea pigs maintained on 7.5% casein (0), 30%o casein
(A), or commercial chow (0); vertical bars indicate
standard error of the mean.
centrations (Fig. 2A). In the group consuming
the 7.5% casein diet, total protein levels were
already significantly reduced compared to chow
controls at 4 weeks, and declined markedly to
less than 5 g/dl by 8 weeks. In the 30% casein
group, a slight reduction was seen at 4 weeks,
but there were no significant differences from
the chow control thereafter. A similar pattern
was observed in the response of serum albumin
(Fig. 2B), which was subnormal at 4 weeks in
the 7.5% casein group and declined further to
less than 2.5 g/dl by 6 weeks. There were no
differences in the mean serum albumin concen-
trations of the 30% casein and chow groups at
any interval.
Time course of M. bovis BCG infection. Figure
3 illustrates the influence of diet on the recovery
of viable M. bovis BCG from the inguinal lymph
nodes draining the vaccination site (Fig. 3A) and
subcutaneous vaccination site itself (Fig. 3B). In
all animals, the number of viable M. bovis BCG
increased between 4 and 6 weeks and then
declined by week 8 postvaccination. Total num-
bers of viable mycobacteria were about the same
in both tissues within each treatment group. The
weights of the inguinal lymph nodes and vacci-
nation site were reduced about one-third in the
7.5% casein group at 5, 6, and 8 weeks (0.08 g
versus 0.12 g for lymph nodes; 0.24 g versus 0.32
g for the vaccination site). Significantly more M.
bovis BCG per milligram were recovered from
both tissues taken from protein-deficient (7.5%
casein) guinea pigs than from chow controls,
especially at the 4-, 5-, and 6-week intervals.
Animals consuming the 30% casein diet also had
more viable M. bovis BCG per milligram in both
tissues at 4 weeks and in the inguinal nodes at 5
weeks. There was no significant difference be-
tween bacillary populations of the 30%o casein
and chow groups at the later intervals.
Development of delayed hypersensitivity. Fig-
ure 4 documents the influence of dietary treat-
ment and time postvaccination on the size of
delayed hypersensitivity reactions after intra-
dermal tests with 100 tuberculin units of PPD.
Reactions were minimal in all diet groups 4
weeks after vaccination, but increased rapidly in
the chow controls to reach a plateau of 18 to 20
mm of induration by 6 and 8 weeks. A modest
increase in responsiveness was observed in the
two groups consuming purified diets at 5 weeks,
after which no further change was observed in
the protein-deficient (7.5% casein) guinea pigs.
In contrast, PPD reactivity continued to in-
crease in the 30%o casein group, although the
skin tests were never as large on the average as
those of the chow controls. At 6 and 8 weeks, all
of the chow and 30% casein animals had measur-
able reactions to PPD, whereas some of the
7.5% casein guinea pigs were completely anergic
and those which responded had much smaller
areas of induration distributed over a range of
reaction sizes from 0 to 10 mm of induration.
Lymphocyte blastogenesis. The effect of diet
on the mitogenic responses of peripheral blood
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FIG. 2. Effect of duration of diet on total serum
proteins (A) and serum albumin (B) of M. bovis BCG-
vaccinated guinea pigs maintained on 7.5% casein (0),
30%o casein (A), or commercial chow (0); vertical bars
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FIG. 3. Time course of M. bovis BCG in
the inguinal lymph nodes (A) and vaccinatic
of guinea pigs maintained on 7.5% casein
casein (A), or commercial chow (0); ver
indicate standard error of the mean.
phytohemagglutinin, is summarized in
The optimum dilution of phytohema
varied slightly from animal to animal, t
was no detectable effect of diet on t
response. Although the blastogenic resp
lymphocytes from guinea pigs fed the
sein diet were routinely lower than the
responses, the differences were not sta
significant at any interval. In contrast
cant impairment of blastogenesis was e
at all intervals in lymphocytes taken fi
tein-deficient (7.5% casein) guinea pig,
over, there was a progressive deterioi
lymphocyte responses in vitro with ii
duration of dietary deficiency. By 8 we
response of the 7.5% casein group was c
tenth that of control.
DISCUSSION
Malnutrition impairs the ability of gui
to respond immunologically to infecti
viable M. bovis BCG. Animals fed a
deficient diet (7.5% casein) beginning or
of vaccination did not control the accui
] of viable M. bovis BCG in the vaccination site
and draining lymph nodes as successfully as the
protein-adequate (30% casein) or chow control
groups (Fig. 3). In spite of this increased anti-
genic stimulation, the delayed hypersensitivity
responses to PPD in the 7.5% casein group were
weak or absent, implying that the development
of cell-mediated immunity to mycobacterial anti-
gens was impaired. A possible mechanism for
this impairment is suggested by the hyporespon-
siveness of peripheral blood thymus-dependent(T) lymphocytes from protein-deficient guinea
pigs to stimulation in vitro with a polyclonal
S mitogen (Table 1).
Our previous experience with guinea pigs sug-
gested that slow adaptation to the purified diets
resulted in growth retardation even in the pro-
tein-adequate (30% casein) group (24a). In the
present study, the 30% casein group demonstrat-
ed some of the hallmarks of marasmus in chil-
dren, with low body weight but no significant
reduction in total serum proteins or serum albu-
min. This marasmus-like condition had a mea-
surable effect on delayed hypersensitivity reac-
tions to PPD, even at 8 weeks when the growth
rates and serum protein and albumin levels of
the 30% casein and chow control groups were
comparable (see Fig. 4). Our results are similar
to published reports of reduced tuberculin reac-
tions in moderately underweight M. bovis BCG-
fection in vaccinated children (12, 13, 23, 34). Some work-
ste(B) ers have reported little effect of clinicalin site (B)marasmus on delayed hypersensitivity after vac-
tical bars cination with M. bovis BCG (25, 29, 31), where-
as others have demonstrated significant impair-
ment of PPD reactions in such children (1, 24).
Table 1. Heresi and colleagues have found impaired T
gglutinin lymphocyte blastogenesis in spleen cells of se-
but there verely calorie-restricted rats (14), but demon-
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FIG. 4. Development of delayed hypersensitivity
reactions to 100 tuberculin units of PPD in M. bovis
BCG-vaccinated guinea pigs maintained on 7.5% ca-
sein (0), 30% casein (A), or commercial chow (0);
vertical bars indicate standard error of the mean.
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phokine, leukocyte inhibitory factor, by the cells
of marasmic children (15). Our results suggest
that a history of calorie restriction in the guinea
pig, as expressed by low body weight, is accom-
panied by a measurable delay in the develop-
ment of delayed hypersensitivity, but is not
reflected in the other measures of immune re-
sponse (that is, numbers of viable M. bovis
BCG, lymphocyte blastogenesis), which are ad-
versely affected by protein malnutrition. The
timing of the immunization with respect to the
nutritional insult is probably critical, since Kos-
ter et al. have observed retarded development of
delayed hypersensitivity in children immunized
before nutritional rehabilitation was initiated
(17).
As in previous studies, restricted protein in-
take (7.5% casein) for several weeks produced a
nutritional state in guinea pigs similar to protein-
calorie malnutrition in children, with low body
weight accompanied by significant reductions in
total serum proteins and albumin. We have
already demonstrated that serum albumin levels
in guinea pigs are correlated positively with
some immunological functions, such as delayed
hypersensitivity and lymphocyte blastogenic re-
sponses in vitro (24b). Bhuyan and co-workers
have reported previously that protein-malnour-
ished guinea pigs and rabbits responded poorly
to PPD and did not develop a normal granuloma-
tous response after M. bovis BCG vaccination
(3, 4). The biological validity of our model
system is evident from the similarity between
our results and studies of cell-mediated immuni-
ty in humans with protein-calorie malnutrition.
Several groups have reported reduced skin reac-
tivity and T lymphocyte hyporesponsiveness
after M. bovis BCG vaccination of children with
protein-calorie malnutrition (1, 24, 28, 31).
Although the number of viable M. bovis BCG
recovered from the injection site and draining
nodes was significantly greater in the protein-
deficient (7.5% casein) group, the population
declined markedly between 6 and 8 weeks post-
vaccination (see Fig. 3). This indicates that the
development of effective acquired cellular resist-
ance was delayed, but not abolished, by malnu-
trition. It is important to note that apparent
control of M. bovis BCG accumulation occurred
in the 7.5% casein group without concomitant
conversion to PPD skin test reactivity (see Fig.
4). This suggests that delayed hypersensitivity
may not be a useful indicator of host response to
M. bovis BCG vaccination. Protein-deficient
guinea pigs demonstrated enhanced macrophage
enzymatic activity in previous studies, suggest-
ing a mechanism by which M. bovis BCG levels
might be controlled even in the absence of a
strong T cell response (24b). Alternatively, the
decline observed in viable M. bovis BCG in the
malnourished animals may not be due to specific
immunity but rather to deteriorating tissue con-
ditions which are unable to support growth of
the organisms. Other workers have observed
increased mycobacterial populations in histolog-
ical sections of tissues taken from protein-mal-
nourished guinea pigs, but the viability of these
organisms was not determined (3).
Collins and Auclair reported essentially no
growth of viable M. bovis BCG at the vaccina-
tion site and peak numbers in draining nodes
much earlier in a study of normal guinea pigs (7).
The discrepancies between their results and our
observations in chow control animals are likely
due to differences in M. bovis BCG vaccine
strain and dose. Collins et al. injected more than
106 viable M. bovis BCG per guinea pig, 1,000-
fold more than in the present study. The advan-
tage of employing minimal effective doses of M.
bovis BCG to increase the discriminating power
between levels of acquired resistance has al-
ready been demonstrated (19).
Delayed hypersensitivity to PPD is widely
used as an indicator of host defense status and
M. bovis BCG vaccine efficacy in humans. Un-
fortunately, skin test reactions are impaired by
both severe and moderate malnutrition in the
very populations which would benefit most from
protection against tuberculosis. Our results indi-
cate that the PPD skin test is sensitive both to
protein deprivation and a past history of reduced
food intake, whereas only protein deprivation is
accompanied by deranged lymphocyte function
in vitro and temporary impairment of acquired




4 wk 5 wk 6 wk 8 wk
Chow 33.4 7.5b (5)C 35.2 + 9.0 (5) 46.1 + 12.4 (5) 29.0 + 6.5 (5)
30%o Casein 21.2 ± 4.8 (7) 22.9 t 7.4 (7) 34.3 t 7.6 (10) 20.3 t 4.9 (6)
7.5% Casein 10.4 t 3.9 (7)d 5.3 t 2.9 (7)d 3.3 t 1.9 (5)d 2.8 t 0.6 (5)d
a Ratio of counts per minute in stimulated versus unstimulated cultures.
b Mean t standard error of the mean.
c Number of observations contributing to the mean.
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cellular resistance in vivo. The implications of
these observations for the use of M. bovis BCG
in preventing clinical tuberculosis in malnour-
ished populations are emphasized by the recent
M. bovis BCG field trial failure in India (33). An
experimental approach utilizing low-level respi-
ratory infection of malnourished M. bovis BCG-
vaccinated guinea pigs with M. tuberculosis
should help to clarify this question (16).
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